Halozyme Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $943M | 13M | 73.34 |
| 2025-06-30 | $687M | 13M | 52.02 |
| 2025-03-31 | $1.1B | 17M | 63.81 |
| 2024-12-31 | $840M | 18M | 47.81 |
| 2024-09-30 | $998M | 17M | 57.24 |